{"transactions":[{"id":4616991,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-14T20:28:25.000Z","date":"2026-09-11","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":33589,"derivative":{"exercise_price":3.9396,"expiration_date":"2031-04-13","underlying":"Class A Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001861684-26-000006","document":"form4-09142026_080921.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000186168426000006/form4-09142026_080921.xml","form_type":"4"}},{"id":4616990,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2026-09-14T20:28:25.000Z","date":"2026-09-11","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":3.9396,"value":19698.0,"ownership":{"direct":true},"balance_after":80754,"source":{"system":"sec-edgar","filing":"0001861684-26-000006","document":"form4-09142026_080921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000186168426000006/form4-09142026_080921.xml","form_type":"4"}},{"id":841815,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-16T18:52:14.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":38589,"derivative":{"exercise_price":3.9396,"expiration_date":"2031-04-13","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001861684-26-000005","document":"form4-03162026_100309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000186168426000005/form4-03162026_100309.xml","form_type":"4"}},{"id":841814,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2026-03-16T18:52:14.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":3.9396,"value":39396.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,032 shares acquired pursuant to the Company's 2021 Employee Stock Purchase Plan."}],"balance_after":75754,"source":{"system":"sec-edgar","filing":"0001861684-26-000005","document":"form4-03162026_100309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000186168426000005/form4-03162026_100309.xml","form_type":"4"}},{"id":882163,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2026-02-25T20:00:18.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":3117,"price":41.9839,"value":130863.8163,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The trading order for shares sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) of all participants for the Issuer, including the Reporting Person, occurred over a period of two (2) business days, beginning on February 23, 2026 and ending on February 24, 2026."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to solely satisfy tax withholding obligations incurred upon vesting of restricted stock units. The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.005 to $42.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":64722,"source":{"system":"sec-edgar","filing":"0001861684-26-000004","document":"form4-02262026_010213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000186168426000004/form4-02262026_010213.xml","form_type":"4"}},{"id":916134,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-06T20:00:16.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the stock option will vest and become exercisable on March 4, 2026, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":42.74,"expiration_date":"2036-02-03","underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001861684-26-000002","document":"form4-02062026_080213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000186168426000002/form4-02062026_080213.xml","form_type":"4"}},{"id":916133,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2026-02-06T20:00:16.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Class A Common Stock underlying the restricted stock units (\"RSUs\") granted under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":67839,"source":{"system":"sec-edgar","filing":"0001861684-26-000002","document":"form4-02062026_080213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000186168426000002/form4-02062026_080213.xml","form_type":"4"}},{"id":1000411,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-13T20:57:37.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the option vest on March 9, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":48589,"derivative":{"exercise_price":3.9396,"expiration_date":"2031-04-13","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-25-280792","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000119312525280792/ownership.xml","form_type":"4"}},{"id":1000410,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2025-11-13T20:57:37.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":3.9396,"value":39396.0,"ownership":{"direct":true},"balance_after":57839,"source":{"system":"sec-edgar","filing":"0001193125-25-280792","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000119312525280792/ownership.xml","form_type":"4"}},{"id":1000409,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2025-11-13T20:57:37.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":29.0583,"value":435874.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $29.03 to $29.17, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 893 ordinary shares acquired pursuant to the Company's 2021 Employee Stock Purchase Plan."}],"balance_after":47839,"source":{"system":"sec-edgar","filing":"0001193125-25-280792","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000119312525280792/ownership.xml","form_type":"4"}},{"id":1256058,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-20T16:13:15.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of the shares subject to the stock option will vest and become exercisable on March 18, 2025, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":21500,"derivative":{"exercise_price":29.18,"expiration_date":"2035-02-17","underlying":"Class A Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001415889-25-004851","document":"form4-02202025_090211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000141588925004851/form4-02202025_090211.xml","form_type":"4"}},{"id":1256057,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2025-02-20T16:13:15.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":10740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Class A Common Stock underlying the restricted stock units (\"RSUs\") under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":61946,"source":{"system":"sec-edgar","filing":"0001415889-25-004851","document":"form4-02202025_090211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000141588925004851/form4-02202025_090211.xml","form_type":"4"}},{"id":1511728,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-17T16:21:06.000Z","date":"2024-05-16","kind":"exercise","planned":false,"acquired":false,"shares":20651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48 of the total stock option vests and becomes exercisable monthly on the same day of each month following February 15, 2023, subject to continuous service of the Reporting Person on each vesting date."}],"balance_after":69349,"derivative":{"exercise_price":7.87,"expiration_date":"2033-02-14","underlying":"Class A Common Stock","underlying_shares":20651},"source":{"system":"sec-edgar","filing":"0001415889-24-013504","document":"form4-05172024_080555.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000141588924013504/form4-05172024_080555.xml","form_type":"4"}},{"id":1511727,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-17T16:21:06.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":false,"shares":8221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":58589,"derivative":{"exercise_price":3.9396,"expiration_date":"2031-04-13","underlying":"Class A Common Stock","underlying_shares":8221},"source":{"system":"sec-edgar","filing":"0001415889-24-013504","document":"form4-05172024_080555.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000141588924013504/form4-05172024_080555.xml","form_type":"4"}},{"id":1511726,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2024-05-17T16:21:06.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":43.029,"value":107572.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.01 to $43.08, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":51206,"source":{"system":"sec-edgar","filing":"0001415889-24-013504","document":"form4-05172024_080555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000141588924013504/form4-05172024_080555.xml","form_type":"4"}},{"id":1511725,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2024-05-17T16:21:06.000Z","date":"2024-05-16","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":7.87,"value":19675.0,"ownership":{"direct":true},"balance_after":53706,"source":{"system":"sec-edgar","filing":"0001415889-24-013504","document":"form4-05172024_080555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000141588924013504/form4-05172024_080555.xml","form_type":"4"}},{"id":1511724,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2024-05-17T16:21:06.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":18151,"price":42.219,"value":766317.069,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.86, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":51206,"source":{"system":"sec-edgar","filing":"0001415889-24-013504","document":"form4-05172024_080555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000141588924013504/form4-05172024_080555.xml","form_type":"4"}},{"id":1511723,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2024-05-17T16:21:06.000Z","date":"2024-05-16","kind":"exercise","planned":false,"acquired":true,"shares":18151,"price":7.87,"value":142848.37,"ownership":{"direct":true},"balance_after":69357,"source":{"system":"sec-edgar","filing":"0001415889-24-013504","document":"form4-05172024_080555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000141588924013504/form4-05172024_080555.xml","form_type":"4"}},{"id":1511722,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2024-05-17T16:21:06.000Z","date":"2024-05-15","kind":"sale","planned":false,"acquired":false,"shares":1965,"price":42.68,"value":83866.2,"ownership":{"direct":true},"balance_after":51206,"source":{"system":"sec-edgar","filing":"0001415889-24-013504","document":"form4-05172024_080555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000141588924013504/form4-05172024_080555.xml","form_type":"4"}},{"id":1511721,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2024-05-17T16:21:06.000Z","date":"2024-05-15","kind":"sale","planned":false,"acquired":false,"shares":8221,"price":42.17,"value":346679.57,"ownership":{"direct":true},"balance_after":53171,"source":{"system":"sec-edgar","filing":"0001415889-24-013504","document":"form4-05172024_080555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000141588924013504/form4-05172024_080555.xml","form_type":"4"}},{"id":1511720,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2024-05-17T16:21:06.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":true,"shares":8221,"price":3.9396,"value":32387.4516,"ownership":{"direct":true},"balance_after":61392,"source":{"system":"sec-edgar","filing":"0001415889-24-013504","document":"form4-05172024_080555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000141588924013504/form4-05172024_080555.xml","form_type":"4"}},{"id":1542642,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2024-04-12T16:02:22.000Z","date":"2024-04-10","kind":"sale","planned":false,"acquired":false,"shares":5714,"price":40,"value":228560.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,831 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on March 13, 2024."}],"balance_after":53171,"source":{"system":"sec-edgar","filing":"0001415889-24-010753","document":"form4-04122024_080416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000141588924010753/form4-04122024_080416.xml","form_type":"4"}},{"id":1676565,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-18T16:06:19.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":81250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the shares subject to the stock option will vest and become exercisable on February 16, 2024, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":81250,"derivative":{"exercise_price":16.8,"expiration_date":"2034-01-15","underlying":"Class A Common Stock","underlying_shares":81250},"source":{"system":"sec-edgar","filing":"0001415889-24-001518","document":"form4-01182024_090112.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000141588924001518/form4-01182024_090112.xml","form_type":"4"}},{"id":1676564,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE, CHIEF ACCT OFFCR"}}],"security":"Class A Common Stock","published_at":"2024-01-18T16:06:19.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":21875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Class A Common Stock underlying the restricted stock units (\"RSUs\") under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on September 13, 2023."}],"balance_after":57054,"source":{"system":"sec-edgar","filing":"0001415889-24-001518","document":"form4-01182024_090112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000141588924001518/form4-01182024_090112.xml","form_type":"4"}},{"id":1834110,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance, Chief Acct Offcr"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-06T16:05:49.000Z","date":"2023-07-05","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":66810,"derivative":{"exercise_price":3.9396,"expiration_date":"2031-04-13","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-041521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000120919123041521/doc4.xml","form_type":"4"}},{"id":1834109,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance, Chief Acct Offcr"}}],"security":"Class A Common Stock","published_at":"2023-07-06T16:05:49.000Z","date":"2023-07-05","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":3.9396,"value":39396.0,"ownership":{"direct":true},"balance_after":32679,"source":{"system":"sec-edgar","filing":"0001209191-23-041521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000120919123041521/doc4.xml","form_type":"4"}},{"id":2007977,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance, Chief Acct Offcr"}}],"security":"Class A Common Stock","published_at":"2023-02-17T16:19:19.000Z","date":"2023-02-06","kind":"purchase","acquired":true,"shares":5714,"price":7,"value":39998.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The reporting person's original Form 4 contained a typographical error on the transaction date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Shares purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 6, 2023.  The purchase price is the offering price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 817 shares acquired under the Issuer's Employee Stock Purchase Plan on September 13, 2022."}],"balance_after":22679,"source":{"system":"sec-edgar","filing":"0001209191-23-010595","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000120919123010595/doc4a.xml","form_type":"4/A","original_submission_date":"2023-02-08"}},{"id":2007976,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance, Chief Acct Offcr"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-17T16:14:40.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the total stock option will vest and become exercisable monthly on the same day of each month following February 15, 2023, subject to continuous service of the Reporting Person on each vesting date."}],"balance_after":90000,"derivative":{"exercise_price":7.87,"expiration_date":"2033-02-14","underlying":"Class A Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-23-010554","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000120919123010554/doc4.xml","form_type":"4"}},{"id":2026671,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance, Chief Acct Offcr"}}],"security":"Class A Common Stock","published_at":"2023-02-08T16:05:26.000Z","date":"2022-02-06","kind":"purchase","acquired":true,"shares":5714,"price":7,"value":39998.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 6, 2023.  The purchase price is the offering price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 817 shares acquired under the Issuer's Employee Stock Purchase Plan on September 13, 2022."}],"balance_after":22679,"source":{"system":"sec-edgar","filing":"0001209191-23-007770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000120919123007770/doc4.xml","form_type":"4"}},{"id":2176263,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance, Chief Acct Offcr"}}],"security":"Class A Common Stock","published_at":"2022-08-23T16:08:33.000Z","date":"2022-08-19","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Class A Common Stock underlying the restricted stock units (\"RSUs\") under Issuer's 2021 Equity Incentive Plan.  One-third of the RSUs vest on August 20, 2023, rounded to the nearest whole share, and the remaining RSUs vest on August 20, 2024, subject to the Reporting Person's continuous service through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,148 shares acquired under the Issuer's Employee Stock Purchase Plan on March 11, 2022."}],"balance_after":16148,"source":{"system":"sec-edgar","filing":"0001209191-22-047167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000120919122047167/doc4.xml","form_type":"4"}},{"id":2385745,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance, Chief Acct Offcr"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-18T16:10:21.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":36729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the total stock option will vest and become exercisable monthly on the same day of each month following February 16, 2022, subject to continuous service of the Reporting Person on each vesting date."}],"balance_after":36729,"derivative":{"exercise_price":20.94,"expiration_date":"2032-02-15","underlying":"Class A Common Stock","underlying_shares":36729},"source":{"system":"sec-edgar","filing":"0001209191-22-011220","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000120919122011220/doc4.xml","form_type":"4"}},{"id":2710546,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":60674,"kind":"person","name":"Young Joseph R","position":1,"cik":"0001861684","reported_name":"Young Joseph R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance, Chief Acct Offcr"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-17T20:30:51.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":13722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the option vest on May 13, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":13722,"derivative":{"exercise_price":11,"expiration_date":"2031-05-12","underlying":"Class A Common Stock","underlying_shares":13722},"source":{"system":"sec-edgar","filing":"0001209191-21-033332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861684/000120919121033332/doc4.xml","form_type":"4"}}]}